🇺🇸 mRNA-4157 in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 8

Most-reported reactions

1. Constipation — 1 report (12.5%)
2. Dry Skin — 1 report (12.5%)
3. Hypertension — 1 report (12.5%)
4. Oral Pain — 1 report (12.5%)
5. Pyrexia — 1 report (12.5%)
6. Rash — 1 report (12.5%)
7. Thyroid Disorder — 1 report (12.5%)
8. Thyroid Function Test Abnormal — 1 report (12.5%)

Source database →

Frequently asked questions

Is mRNA-4157 approved in United States?

mRNA-4157 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for mRNA-4157 in United States?

ModernaTX, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.